Structure Therapeutics Appoints Ted W Love, M D , to Board of Directors tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Syros Pharmaceuticals Inc received notice from Pfizer Inc (NYSE: PFE), as successor to Global Blood Therapeutics Inc, exercising its right to terminate the License and Collaboration Agreement dated December 17, 2019, related to the discovery, development, a
(Reuters) - Syros Pharmaceuticals said on Friday Pfizer will terminate a license deal between the companies related to the development of novel therap.
Shares of Syros were down 5.7% in trading after the bell. The termination will end the company's more than three-year long collaboration with sickle cell disease drugmaker Global Blood Therapeutics (GBT) that Pfizer bought in a $5.4 billion deal last August.